|
| 'Chitosan (1) | 1 (2) | 1, 3, 4 - oxadiazoles (1) |
| 1,2,3,4-tetrahydro-9Hpyrido [3,4-b] indole-3-carboxylic acid (1) | 1,3,4-Oxadiazole (1) | 1,3,4-Oxadiazoles (1) |
| 1-butyl-3-methyl imidazolium bromide (1) | 1-butyl-3-methyl imidazolium chloride. (1) | 1-methyl-4-phenyl-1 (1) |
| 12-Dimethylbenz[a]anthracene (1) | 18 β-glycyrrhetic acid (1) | 2 (2) |
| 2, 5-diaza bicyclo [4.3.1] compounds (1) | 2,2-diphenyl-1-picrylhdrazyl (1) | 2-(N-hydroxymethyl amino)-indol-3-yl-propanoic acid (1) |
| 2-aminobenzothiazole (1) | 2-Hydroxypropyl-β-cyclodextrin (1) | 23 factorial design (1) |
| 25(OH)2D (1) | 3 (2) | 3-Methyl-2-benzothiazonium hydrazone hydrochloride (1) |
| 32 factorial design (1) | 3D QSAR (1) | 3D-QSAR (1) |
| 3’ UTR region (1) | 4 - acetamido phenoxy acetyl hydrazide (1) | 4-dihydroxy-4-methoxybenzophenone- 2-O-β-d-glucopyranoside (1) |
| 4-pyridinecarboxylic acid hydrazide (1) | 4-Thiadiazole-2-amine (1) | 5-fluoroindolin-2-one (1) |
| 5-Fluorouracil (1) | 5-HT 3 receptor antagonists (1) | 5-Piperazinedione (1) |
| 6 (1) | 6-beta naltrexol (1) | 6-Mercaptopurine (1) |
| 6-Methylmercaptopurine (1) | 6-tetrahydropyridine (MPTP) (1) | 7 (1) |
| 7-Hydroxy warfarin. (1) | 8-iso-Prostaglandin F2α (1) | 99mTc-ciprofloxacin (1) |
| A. nilotica (1) | ABC analysis (5) | ABC-VED matrix (4) |
| ABC-VEN analysis (1) | Abdominal Pregnancy (1) | Abheshaja (1) |
| Absorbance ratio (1) | Absorption ratio (1) | ABTS (1) |
| Abuse (1) | Academic Stressors scale (1) | Acalypha indica (1) |
| Acarbose (1) | Accuracy. (1) | Accurate (1) |
| ACE (2) | ACE inhibitor (1) | Aceclofenac (1) |
| ACEIs (1) | Acetaminophen (1) | Acetazolamide (1) |
| Acetic acid induced rat colitis (1) | acetic acid induced writhing test (1) | Acetyl cholinesterase estimation (1) |
| Acetyl isoniazid (1) | Acetylation rate (1) | Acetylcholinesterase (4) |
| Acetylcholinesterase inhibitors (1) | ACF (1) | Acid hydrolysis (1) |
| Acid violet 43 (1) | Acid-resistant capsules (1) | Acne (2) |
| Acne vulgaris (1) | Aconitine (1) | Acquired immune deÞ ciency syndrome (1) |
| Acrylamide grafted ghatti gum; Biodegradable; Diclofenac sodium; pH-sensitive hydrogel; Controlled-release. (1) | Act score (1) | Actinomycetes (1) |
| Activator procaspase-3 (1) | active pharmaceutical ingredient (1) | Active site (1) |
| Activities of daily living (ADL) scale (1) | Activity domain (1) | Acupuncture (1) |
| Acute appendicitis (1) | Acute generalized exanthematous pustulosis (1) | Acute Inflammation (1) |
| Acute inß ammation (1) | Acute Kidney Damage (1) | Acute poisoning (1) |
| Acute Severe Pancreatitis (1) | Acute Side Effects (1) | Acute ST segment elevation myocardial infarction (1) |
| Acute toxicity (1) | acyclovir (2) | ADE (1) |
| Adenanthera (1) | Adenosine A 2A antagonist (1) | Adherence (5) |
| Adherence. (1) | Adiantum venustum (1) | Adjuvant therapy (1) |
| ADME properties. (1) | Adnexal masses (1) | ADR (2) |
| ADR (Adverse Drug Reaction) (3) | ADR management (1) | ADR monitoring centre (AMC). (1) |
| ADR reporting (1) | ADR(Adverse Drug Reaction) (1) | ADRs (2) |
| Adsorbent (1) | Adverse drug event (1) | adverse drug events (1) |
| Adverse drug reaction (12) | Adverse Drug Reaction (ADR) (1) | Adverse Drug Reaction and Antihypertensive medications. (1) |
| Adverse Drug Reaction Reporting Systems (1) | Adverse drug reaction. (1) | Adverse Drug Reactions (9) |
| Adverse drug reactions (ADRs) (1) | Adverse event following immunization (AEFI) (1) | Adverse events (2) |
| Adverse reaction (1) | Aedes aegypti (2) | Aerobic exercise (1) |
| Aerosil (1) | affective ; assessment ; cognitive ; learning domains ; psychomotor (1) | Age (2) |
| Ageratum conyzoides L (1) | Agrobacterium (1) | air pollution (1) |
| Airjet (1) | Albendazole (1) | Albino mice (1) |
| Albino wistar rats (1) | Alcohol (2) | Alcohol withdrawl seizure (1) |
| alcoholic extract (1) | ALDEN (1) | Aldose reductase inhibitors (1) |
| Alkaloids (1) | allantoin (1) | Allergic reactions (1) |
| Allergic rhinitis (1) | Allergy (4) | Allium sativum (1) |
| Alloxan (1) | Alloxan monohydrate (1) | Alocasia indica Schott (1) |
| Aloe vera (1) | Alpha mangostin (1) | Alpha-adrenoceptor (1) |
| alpha-delta-bungarotoxin-4 (1) | Alpinia speciosa (1) | Alprazolam (1) |
| Alteration of drug cost (1) | Altered Mental Status (AMS) (1) | alternative therapy (1) |
| Aluminium chloride (2) | Alzheimer's disease (1) | Alzheimers disease (1) |
| Alzheimer’s disease (1) | Amaranthus spinosus Linn (1) | Amber (1) |
| Ambroxol hydrochloride (1) | Ambulatorial Surgery Procedures (1) | Amides (1) |
| Amikacin Sulfate (1) | Amino acids (1) | amino benzylated Mannich bases (1) |
| Amisulpride (1) | amivudine (1) | Amlodipine (2) |
| Amlodipine besylate (2) | Ammonium salts (1) | Amoora cucullata. (1) |
| amoxicillin (1) | Amoxicillin sodium (1) | Anabolic steroids (1) |
| Anabolic. (1) | Anaemia (2) | Analgesia (1) |
| analgesic (9) | Analgesic effect (1) | analgesic- anti-inß ammatory activity (1) |
| Analgesics (1) | Analysis in capsules (1) | Analysis of variance (1) |
| Anaphylactic shock (1) | Anaphylaxis. (1) | and TGF–β (1) |
| Andragogy (1) | Anemia (2) | Anethole (1) |
| Anethum graveolens (1) | Angiogenesis (1) | Angiogenic growth factors (1) |
| Angiotensin Converting Enzyme Inhibitors (1) | Animal model (1) | Ankylosing spondylitis (1) |
| antepartum (1) | anthelmintic (1) | anthelmintic property (1) |
| Anthocyanin (1) | Anthracyclines (2) | Anti aging (1) |
| Anti hyperglycemic (1) | Anti inflammatory (1) | Anti-amnesia (2) |
| anti-anxiety activity (1) | Anti-anxiolytic (1) | Anti-asthmatic activity (1) |
| Anti-Cancer Activity (1) | Anti-diabetes mellitus. (1) | Anti-diabetic drugs (1) |
| Anti-epileptic (1) | Anti-epileptic drugs utilization (1) | Anti-HIV (1) |
| anti-hypertensive agent (1) | Anti-infective (2) | Anti-infective agents (1) |
| anti-inflammation (1) | anti-inflammatory (7) | Anti-inflammatory Activities of Total Leaf Extracts of Ficus sycomorus L. (Moraceae) used in Traditional Medicine in the Treatment of Sickle Cell Disease (1) |
| anti-inflammatory activity (2) | anti-inflammatory activity', (1) | anti-inflammatory agent (1) |
| anti-inß ammatory (3) | Anti-inß ammatory activity (1) | Anti-obesity (1) |
| Anti-oxidant (2) | Anti-parkinsonism activity (1) | Anti-solvent (1) |
| anti-spasmodic drug (1) | Anti-TB drugs (1) | Anti-tubercular activity (1) |
| Anti-tumor agent (1) | antiamnesic agents (1) | Antianxiety (1) |
| antibacterial (3) | antibacterial activity (4) | Antibacterial drugs (1) |
| Antibiotic (2) | antibiotic guidelines (1) | Antibiotic paste (1) |
| Antibiotic Resistance (3) | Antibiotics (9) | Antibiotics. (1) |
| Anticancer (5) | Anticancer activity (1) | Anticancer drugs (1) |
| Anticholinergic (1) | Anticoagulant (2) | Anticoagulant service (1) |
| anticonvulsant (1) | anticonvulsant activity (1) | anticonvulsants (1) |
| Anticovulsant (1) | Antidepressants (1) | Antidesma bunius (1) |
| Antidiabetic (3) | Antidiabetic activity (2) | Antidiabetic agents (1) |
| antiepileptic agents (1) | Antiepileptic Drugs (3) | antifungal (1) |
| antifungal activity (1) | Antifungal drugs (1) | Antigen (1) |
| antigen protein (1) | Antiglycation (1) | Antihistaminic (2) |
| Antihyperglycemic (1) | Antihypertensive (1) | Antihypertensives (1) |
| Antiinflamatory (1) | Antimalarial (2) | Antimicrobial (4) |
| Antimicrobial activities (1) | Antimicrobial activity (7) | Antimicrobial agent (1) |
| Antimicrobial efficacy (1) | Antimicrobial resistance (2) | Antimicrobial resistance; Prescribing practice; Anti-infective agents; Antibacterials; Pharmacoepidemiology. (1) |
| Antimicrobial Stewardship (1) | Antimicrobials (4) | Antimosquito (1) |
| Antimycotic Activity (1) | antinociceptive (1) | Antioxidant (19) |
| Antioxidant ; carotenoid ; humans ; half-life ; status ; absorption . (1) | Antioxidant activity (8) | antioxidant effect (1) |
| Antioxidant properties (1) | Antioxidants (6) | Antipsychotics (1) |
| antipyretic (2) | Antiretroviral drugs (1) | Antiretroviral therapy (2) |
| Antispasmodic (1) | Antithrombotic (2) | Antithyroid drugs (1) |
| Antitubercular (1) | Antitubercular drugs. (1) | antiulcer (1) |
| Antiurolithiatic activity (1) | Antivenom (1) | Antivenom reactions (1) |
| Antiviral (2) | antiviral activity (1) | Antiviral RNA (1) |
| Anxiety (4) | Anxiolytics (1) | APAP (1) |
| APC (1) | Apoptosis (2) | Application (1) |
| Application to PK profile studies (1) | applications (1) | Appropriateness (1) |
| Aqueous extract (3) | AR Caps (1) | Arabic gum (1) |
| ARBs (1) | ARDS (1) | Area above the blood glucose levels-time curve. (1) |
| area of wound healing (1) | Areca nut (1) | Arginase (2) |
| Arginine (1) | Armodafinil (1) | ART (1) |
| Artemia salina (1) | Artemia salina. (1) | Artemisia (1) |
| Artemisia absinthium (1) | Artemisia macrocephala (1) | arterial hypertension (1) |
| Arterial stiffness (1) | Arteriovenous malformation (AVM) (1) | Arthritis (1) |
| ARV Drugs (1) | Ascorbic acid (3) | Asenapine (1) |
| asian developing nations (1) | Asiaticoside (1) | Asparagus racemosus (1) |
| Asparagus racemosus root extract (1) | Aspergillus niger (2) | Aspergillus niger. (1) |
| Aspergillus terreus (1) | Aspirin (1) | Assay (2) |
| Asthma (6) | Asymptomatic neurocognitive impairment (1) | Ataxia (3) |
| ATC/DDD (3) | Atenolol (1) | Atherosclerosis (1) |
| Atherosclerotic Vascular Disease (1) | Athlete Biological Passport (1) | Atorvastatin (5) |
| Atorvastatin calcium (1) | Atorvastatin. (1) | ATP synthase inhibitor (1) |
| ATP- sensitive K+channel (1) | Atractylis flava Desf (1) | Atrial fibrillation (1) |
| Atropine (1) | Attitude (7) | Attitude and practice (1) |
| Attitude. (1) | Attitudes (1) | Atypical antipsychotics (1) |
| Aucubin (1) | Authors (1) | Authorship issues (1) |
| Autism spectrum disorders (1) | Auto antibody (1) | Auto medication (1) |
| Autoimmune disorders (1) | Autoimmunity (1) | Averrhoa bilimbi (1) |
| Avicel (1) | Awareness (5) | Ayurveda (2) |
| Ayurvedic (1) | Azelaic acid (1) | Azilsartan medoxomil (1) |
| B cell epitope (1) | Bacoside A3 (1) | Bacteremia (1) |
| Bacteria (1) | Bacterial isolates (1) | Bacteriological culture (1) |
| Bacteriostatic (1) | Bamboo betung (1) | Bambusa vulgaris (1) |
| Banana (1) | Bangladesh (2) | bark (1) |
| Barleria cristata (1) | Barriers (1) | Bauhinia purpurea (1) |
| Bauhinia racemosa (1) | Bauhinia variegata (2) | Bay-K-8644 (1) |
| Bayesian confidence propagation neural network (1) | BCG vaccine (1) | BCS-IV drug (1) |
| Beauty Salon Owner (1) | Beck Depression Inventory (1) | Beck Depression Inventory(BDI) (1) |
| Bedaquiline (1) | Behavioral research (1) | Belief (1) |
| Benchmarking (1) | Benzimidazole derivative (1) | benzimidazoles (2) |
| Benzodiazepines (1) | Benzothiazole analogues (1) | Benzo[d]oxazole-2-thiol (1) |
| Berberis integerrima Bunge (1) | Beta-lactamase (1) | Beta-lactamic (1) |
| Bibliometrics (5) | Bilayered floating tablets (1) | Bioactive compound (1) |
| Bioactive Metabolites (2) | Bioactivity (1) | Bioadhesive (1) |
| Bioanalytical (1) | Bioanalytical method (2) | Bioanalytical method development (1) |
| Bioassay (1) | bioavailability (5) | Biodegradable (1) |
| Bioethics (1) | Biofilm (1) | Biohazard (1) |
| Biologics (1) | Biology (1) | Biomaterials (1) |
| Biomedical (1) | Bioprospecting. (1) | Biopsy Proven Acute Rejection (1) |
| Biosafety (1) | Biosafety Engineering Control (1) | Biosimilars (2) |
| Biotechnology (2) | Bisphosphonates (1) | Bitter (1) |
| Black tea extract (1) | BLAST (1) | Bleaching (1) |
| Bleeding time (1) | Bleomycin (1) | Blonanserin (1) |
| Blood brain barrier (1) | Blood glucose (1) | Blood pressure (4) |
| Body Mass Index (1) | Body Mass Index (BMI). (1) | Boerhaavia Diffusa (1) |
| Bone (2) | Book Review (1) | Borg scale (1) |
| botulinum toxin (1) | Box-Behnken (1) | Brahmi vati (1) |
| Brain (1) | Brain targeting (2) | Brand Drugs (1) |
| brand name drugs (1) | Branded medication (1) | Bratton-Marshall reagent (1) |
| Brazil (1) | Breast cancer (6) | Brewer’s yeast (1) |
| Brief COPE scale (1) | Brief medication questionnaire (1) | Brimonidine tartrate (1) |
| brine shrimp lethality bioassay (1) | Brine-shrimp lethality. (1) | Bromelain (1) |
| Bromeliaceae (1) | Bromocresol purple (1) | Bronchial Asthma (2) |
| Bryonia laciniosa (1) | Buccal (1) | Buccal Patches (1) |
| budget forecasting (1) | Bufadienolide (1) | Bullous eruption (1) |
| bungarotoxin (1) | Bungarus caeruleus (1) | Bungur (1) |
| Buni-berry extract (1) | Buoyancy (1) | Buoyant microspheres (1) |
| Burden Of Disease (1) | Business method (1) | Business model (1) |
| Butea monosperma (1) | C-reactive protein (1) | C934 (1) |
| CA125 (1) | Ca2+ channels (1) | Cadmium chloride (1) |
| Caesalpinia decapetala (1) | Caesalpinia pulcherrima (1) | Caesalpinia pulcherrima (L.) Sw. stem bark (1) |
| Caesalpinia sappan (1) | CAGR (1) | Calcineurin inhibitor (1) |
| Calcium (1) | Calcium channel blocking (1) | calcium channel blocking activity (1) |
| Calcium oxalate (1) | Calcium phosphate (1) | Calcium silicate (1) |
| Calendula officinalis (1) | calendula oil (1) | CAM Assay (1) |
| Camelia sinensis extract (1) | Camellia sinensis (1) | Camptothecin (1) |
| Cancer (7) | Cancer Chemotherapy (2) | Cancer treatment (1) |
| Candida (2) | Candida albicans (4) | Candida albicans. (1) |
| CaOx crystal aggregation (1) | CaOx crystal nucleation (1) | Capacity (1) |
| Capsule (1) | capsules (1) | carbamazepin (1) |
| Carbamazepine (2) | carbohydrazide (1) | Carbomyl Linkage (1) |
| carbon tetrachloride (1) | carbonyl compounds (1) | Carbopol (1) |
| Carbopol 940 (1) | Carcinoma. (1) | cardiac arrhythmias (1) |
| Cardiac care (1) | Cardiac remodeling (1) | Cardiology (2) |
| Cardioprotection (1) | Cardioprotective (1) | Cardiotoxicity (2) |
| Cardiovascular disease (1) | Cardiovascular drugs (1) | Career Choices (1) |
| Carica papaya L. (1) | Carnauba wax (1) | carrageenan (2) |
| Caryocar coriaceum (1) | Case report (1) | Casein (1) |
| Casein Phosphopeptide-amorphous calcium Phosphate (1) | Catalase (1) | catalepsy (2) |
| Cation-pi (1) | CationicGuargum (1) | Causality assessment (2) |
| Causality scales (1) | CCKNOW - Crohn’s and Colitis Knowledge assessment questionnaire (1) | CD150 (1) |
| CD244.2 (1) | CD48 (1) | Cefixime (1) |
| Cefotaxime (1) | ceftriaxone and co-amoxiclav (1) | Cefuroxime (1) |
| Cefuroxime Axetil (1) | cell viability Glycyrrhiza glabra (1) | Cellulase (1) |
| Cellulite (1) | Cellulitis (1) | Cellulose (2) |
| Cemented (1) | Cementless (1) | CEN (1) |
| Centella asiatica (3) | Central composite design (4) | Central cord syndrome (1) |
| Central post-stroke pain (1) | Cephalexin (2) | Ceramics (1) |
| Cerebrovascular Accident (1) | Cervical bulge (1) | Cervical dentine hypersensitivity (1) |
| CFFF (1) | chalcone (1) | chalcones (2) |
| Challenges (1) | Chamomile tea (1) | Characterization (4) |
| Chebulinic acid (1) | Chemical stability (1) | Chemiluminescence (1) |
| Chemomechanical removal (1) | Chemometrics (3) | Chemotaxis (1) |
| Chemotherapy (6) | Chewing gum (1) | Child Care (1) |
| Children (2) | Children Dentistry (1) | Chitin (1) |
| Chitosan (7) | Chitosan Acetate. (1) | chitosan microspheres (1) |
| Chitosan nanoparticle (1) | Chitosan-g-HPβCD (1) | Chlamydomonas reinhardtii (1) |
| Chloramphenicol (1) | Chlorhexidine (2) | Chlorohexidine (1) |
| cholesterol (1) | Cholesterol HDL (1) | Cholinesterase inhibitors (1) |
| Chromotropic acid reagent (1) | Chronic hepatitis B (1) | Chronic kidney disease (2) |
| Chronic Obstructive Pulmonary Disease (COPD) and Elderly Patient. (1) | Chrysophyllum cainito L. leaves (1) | Cicer arietinum (1) |
| Cigarette smoke (1) | Cilostazol (1) | Cinnamaldehyde (1) |
| Cinnamic acid derivatives (1) | Cinnamomum cassia (1) | Ciprofloxacin (1) |
| Citronella (1) | Citrus hystrix (1) | Citrus limon (2) |
| CKD (1) | CKMB. (1) | Claims (1) |
| Clarithromycin (1) | Classification (1) | Clastogenicity (1) |
| Cleistanthin A (2) | cleistanthin B (2) | Cleistanthus Collinus (1) |
| Clinical attachment (1) | Clinical attachment level (1) | Clinical efficacy (1) |
| Clinical equivalence (1) | Clinical manifestation (1) | Clinical Pharmacist (1) |
| Clinical pharmacist care (1) | Clinical Pharmacists (1) | Clinical pharmacology (1) |
| Clinical Pharmacy Services (1) | Clinical research (1) | Clinical trial (1) |
| Clinical trials (1) | Clinicians (1) | clonidine (2) |
| Clopidogrel (1) | Clopidogrel bisulfate (1) | Closed melt (1) |
| Clove (1) | cloxacillin (1) | Cluster analysis (1) |
| CME (1) | CNS stimulants (1) | Co-crystal (1) |
| Co-Formers (1) | Co-Morbidity (1) | Co-morbidity. Correspondence (1) |
| co-precipitation method (1) | Co-surfactant (1) | Cochlopermum tinctorium (1) |
| coding system (1) | Cognition (2) | Cognitive impairment (1) |
| Cogrinding (1) | Colloidal carriers (1) | Colloidal silicone dioxide (1) |
| Colon targeted delivery (1) | Colon targeted drug delivery. (1) | Colon targeting (1) |
| Colonic delivery (1) | Colorectal cancer (1) | colorimetric assay (1) |
| Column chromatography (1) | Combination tablet (1) | Combination Therapy (1) |
| Combinatorial effect (1) | Comet assay (1) | common cold (1) |
| common cold and cough (1) | Common warts (1) | Community Pharmacies (2) |
| Community pharmacist (3) | Community Pharmacists (2) | Community pharmacy (2) |
| Community Pharmacy Patient Questionnaire (1) | Comorbidity (1) | Comparative dissolution (1) |
| comparative molecular similarity indices (1) | comparative molecular Þ eld analysis (1) | Comparison (1) |
| compensation (1) | Complementary and alternative medicine (2) | complementary and alternative medicines (1) |
| Complementary and alternative therapy (1) | complete epithelization (1) | Complexation (1) |
| Compliance (1) | compound 48/80 (2) | compritol 888 ATO (1) |
| Computer (1) | Computer literacy (1) | computer-aided instructions (1) |
| Computer-aided learning (1) | Computerized screening systems (1) | CoMSIA (1) |
| Conessine (1) | Constipation (1) | Consumer (1) |
| Consumer perception (1) | Consumer’s Perception (1) | Content validation (1) |
| content validity (1) | continuing education (1) | Continuous Pharmacy Education. (1) |
| Contract research (1) | Contract research organizations (1) | Control (1) |
| Controlled release (4) | convolution (1) | convulsions (1) |
| cooperative practice (1) | COPD (2) | Coprocessed excipient (1) |
| Cordia obliqua (1) | Corneal opacities (1) | Coronally advanced flap (1) |
| Correlation (2) | Corticosteroid (2) | Corticosteroids (2) |
| Cosmetic (2) | Cosmetic products (1) | Cosmetics (1) |
| Cosmetics use-related adverse reactions (1) | Cosolvency (1) | Cost analysis (1) |
| Cost avoidance (1) | Cost Minimization (1) | Cost of illness (2) |
| Cost saving (1) | Cost-effectiveness analysis (1) | Cost. (1) |
| Costing Analysis. (1) | Cotton dust (1) | Cotton oil (1) |
| cotton pellet (1) | Cough (1) | Cough medicine (1) |
| cough. (1) | Counterfeit Pharmaceutical Products (1) | CPs (1) |
| Cramer’s Matrix method (1) | CRC (1) | Cream (1) |
| creatinine (1) | Crinum asiaticum (1) | CRISPR/Cas9 (1) |
| Critical Care Unit (CCU) (1) | Critical Material attributes (1) | Critical Quality Attributes (1) |
| Critical Thinking (1) | cromolyn sodium (1) | Cronbach’s alpha (1) |
| Croscarmellose sodium (CCS) (1) | Crospovidone (1) | Crospovidone (CP) (1) |
| Cross carmellose sodium (1) | cross-linking agents (1) | Cross-sectional study (1) |
| Crossandra (1) | Croton zehntneri (2) | Crystallinity (2) |
| CTCAE (1) | CTEPH (1) | Cucumis metuliferus (1) |
| Cucumis sativus (1) | CUMIN. (1) | Cuminosides (1) |
| Curcuma longa (1) | Curcumin (3) | current indian scenario of drug interactions (1) |
| Curriculum (1) | curriculum development (1) | Cutaneous Adverse Drug Reactions (CADRs) (1) |
| Cutaneous reaction (1) | CXCR4 (1) | Cyclodextrin (1) |
| Cyclooxegenase-2 inhibitor (1) | Cyclooxygenase (1) | cyclophosphamide (1) |
| Cymbopogon citratus (1) | Cynodon dactylon (2) | CYP genes ; South Indian population ; polymorphisms (1) |
| Cyst (1) | Cytochrome P 2C9 (1) | Cytosine (CYS) (1) |
| Cytotoxic (1) | Cytotoxic activity. (1) | Cytotoxic agents (1) |
| Cytotoxicity (3) | CZE (1) | D&C (1) |
| D-optimal design (1) | Daily Defined Dose (1) | Dammam (1) |
| Dapsone (1) | Data mining algorithms (1) | DDX3 (1) |
| Death Receptors (1) | Decision making (1) | Deep vein thrombosis (1) |
| deferasirox (1) | deferiprone (1) | Deficiency (1) |
| Degenerative disc disease (1) | Degradation (1) | Degradation studies (1) |
| Dehydrozingerone (1) | Delignification (1) | Delirium (2) |
| Dementia (1) | democratic government (1) | Dengue (1) |
| Dengue high fever (1) | Dental caries (4) | Dental Caries. (1) |
| Dental implants (1) | dental management (1) | Dental prosthesis. (1) |
| Dental Restoration (1) | Dental Students (1) | Dentistry (2) |
| dentistry. (1) | Dentists (1) | Deodorants (1) |
| Dependence (1) | Depigmentant (1) | Depok Primary Health Care (1) |
| Deprescribing (1) | Depression (3) | Depression 1 (1) |
| Dermatology (1) | Dermatology life Quality Index (1) | Design of experiments. (1) |
| desirability function (1) | Desirability index. (1) | Desmodium gangeticum (1) |
| Desolvation Method (1) | Detorsion (1) | Deuterium (1) |
| device safety (1) | dexamethasone (2) | Dexibuprofen (1) |
| Dextrin (1) | Diabetes (6) | diabetes and diabetic vascular complications (1) |
| Diabetes mellitus (13) | diabetes mellitus, (1) | Diabetes Type-II (1) |
| Diabetes, glucose (1) | diabetic dyslipidemia (1) | Diabetic nephropathy (1) |
| Diabetic retinopathy (1) | Diabetic Wound (1) | Diacerein (1) |
| DiaKure (1) | diclofenac (2) | Diclofenac SLN (1) |
| Diclofenac sodium (1) | Dicloxacillin sodium (1) | Dicots (1) |
| Dicyclomine (1) | differential scanning calorimetry (1) | diffuse transmittance (1) |
| Diffusion method (1) | Dillenia indica (2) | Dilleniaceae (1) |
| Diltiazem Efficacy (1) | Diltiazem hydrochloride (2) | Dimethylpyrimidin-derivatives (1) |
| Dip coating (1) | Diplotropis ferruginea (1) | direct compression (3) |
| Direct to consumer advertising (1) | Directly observed treatment short-course (1) | Directly observed treatment shortcourse (1) |
| Discharge against medical advice (DAMA) (1) | discharge orders (1) | DISCLE (1) |
| Discrepancies (1) | Discriminant analysis (1) | Disease (1) |
| Disease free survival (1) | disintegration (1) | disintegration time (1) |
| Disproportionality Analysis (1) | Dissolution (5) | dissolution enhancement (1) |
| Dissolution rate (1) | Diuretic (1) | Diuretic activity (2) |
| DMAIC (1) | DMH (1) | DNA barcoding (1) |
| DNA damage (1) | DNA fragmentation (1) | docking (6) |
| Docking studies (1) | docking. (1) | Doctor (1) |
| Documentation (1) | Documentation and records (1) | Donepezil hydrochloride (1) |
| Dopamine (1) | Dosage formulation (1) | Dosage regimen (1) |
| Dose-dependent (1) | DOTS (1) | DOTS plus (1) |
| Doxorubicin (2) | Doxorubicin; FRAP assay (1) | Doxycycline (1) |
| DPP-IV (1) | DPPH Assay (1) | DPPH radical scavenging assay (1) |
| DPPH scavenging (1) | DRcaps (1) | DREEM. (1) |
| Dried blood spot. (1) | Dried blood spot; pharmacokinetic; validation; hydrochlorothiazide (1) | droplet size (1) |
| Drug (2) | Drug allergy tests (1) | Drug delivery (1) |
| Drug delivery denture (1) | Drug detailing (1) | drug disposal (2) |
| Drug drug interactions (1) | Drug Hypersensitivity (2) | Drug induced nephrotoxicity (1) |
| Drug Information and Literature Evaluation (1) | drug interaction (2) | Drug interaction (DI) (1) |
| drug interaction management (1) | Drug Interaction probability scale (1) | drug interactions (2) |
| Drug Policies (1) | Drug prescriptions (1) | Drug product (1) |
| Drug Related Problems (4) | Drug related side effects (1) | drug release (1) |
| Drug Resistance (2) | Drug risk ratio (1) | Drug safety (2) |
| Drug Safety. (1) | Drug therapy (1) | Drug utilization (3) |
| drug utilization study (1) | Drug utilization. (1) | drug-drug interactions (5) |
| Drug-related problem (2) | Drug-SLS tablets. (1) | Drugedrug interaction (1) |
| Drugs (3) | Drugs and Cosmetics rules (1) | Drugs of abuse (1) |
| drug–drug gliclazide (1) | Drug–drug interaction (1) | Dry extract cinnamon (1) |
| Drying techniques (1) | DSPC (1) | Dual Therapy (1) |
| dual-target-directed drugs (1) | Dunaliella salina (1) | Dynamic (1) |
| Dyslipidemias (1) | Dysphagia (1) | E-Cigarettes (1) |
| E-pharmacy websites (1) | e-prescribing (1) | E. coli (1) |
| E.crispa (1) | Early-Related Complications (1) | Eastern province (2) |
| EC50 values (1) | Economic (1) | Economic burden (1) |
| Edaravone (1) | Eddy’s hot plate method. (1) | edema (1) |
| Edible flowers (1) | Editorial (24) | Education (2) |
| Educational excellence (1) | efavirenz (2) | Efficacy. (1) |
| EGCG (1) | Egfr (1) | egg albumin microspheres (1) |
| Elderly (1) | Elderly Patients (1) | Electrochemical (1) |
| electrolyte release (1) | electrolytes (1) | Electron beam radiation (1) |
| Electronic prescribing (1) | Electronic prescription (1) | Electroporation (1) |
| Elevated plus maze (1) | elevated plus maze model (1) | Elisa (1) |
| Ellman’s assay (1) | Emblica offi cinalis (1) | Emergency contraception (1) |
| Emodin (1) | Emotional (1) | Emotional domain (1) |
| Emulgel (1) | Emulsification and Solvent Evaporation (1) | emulsion solvent diffusion method (1) |
| emulsion solvent diffusion-evaporation technique (1) | Encholirium spectabile (1) | Endocrine disruptor (1) |
| Endophytes (1) | Endothelial cells (1) | endothelial Nitric Oxide Synthase (1) |
| Endothelial progenitor cells (1) | Endothelium (1) | Endothelium. (1) |
| Enicostemma littorale (1) | Entire plant (1) | Entrapment afficiency (1) |
| entrapment efficiency (2) | Envenoming (1) | Environmental domain (1) |
| Environmental Factors (1) | Enzymatic hydrolysis (1) | Enzyme kinetics (1) |
| eosinophil (1) | Epigallocatechin Gallate (2) | Epigallocatechin gallate (EGCG) (1) |
| Epigenetics (1) | epilepsy (5) | Epithelial ovarian cancer (1) |
| EQ-5D-5L (1) | EQ5D (1) | ER Matrix (1) |
| erbal drugs (1) | erice declaration (1) | Erythema (1) |
| Erythrina indica (1) | Erythrina variegata (1) | Erythrocyte sedimentation rate (1) |
| Erythroderma (1) | erythropoietin (2) | Escherichia coli (1) |
| Escitalopram oxalate (1) | esomeprazole (1) | Essential drugs (1) |
| Essential hypertension (2) | Essential medicine (1) | essential medicines (1) |
| essential oil (5) | essential oil composition (1) | Essential principles (1) |
| Esthetics Dental (1) | Estimated Glomerular Filtration Rate (1) | Estrogen receptor alpha (1) |
| Ethambutol (1) | Ethanol (1) | Ethanol extract (1) |
| ethanolic extracts (1) | Ethiopia (2) | ethnicity (2) |
| Ethnomedicine (1) | Ethosomes (1) | Ethyl - 4- acetamido phenoxy acetate (1) |
| Ethyl acetate (1) | Ethyl acetate fraction (1) | ethyl cellulose (2) |
| ethylcellulose (3) | ethylene glycol (2) | Etiology (1) |
| Eucalyptus (1) | Eucalyptus hybrid (1) | Eucalyptus oil (2) |
| eudragit (2) | Eudragit RL 100 (1) | eudragit S100 (2) |
| Eudragit-L100 (1) | Eudragit® S100 (1) | Eugenol (1) |
| Euphorbia hirta leaves (1) | Eurycoma Longifolia Jack (1) | Evaluation (1) |
| Ex vivo tissue entrapment (1) | ex-vivo performance (1) | Ex-vivo permeation (1) |
| Ex-vivo study (1) | Exacerbation (1) | Excess Alcohol Consumption (1) |
| Excision wound model (1) | Expectoration (1) | experiences (1) |
| Experiential learning (1) | Experimental ischemic stroke (1) | experimental study (1) |
| Expired medicines (1) | Expiry drugs (1) | Exports (1) |
| Expression profile (1) | Extract (1) | Extrapyramidal side-effects (1) |
| extrinsic stains (1) | extrusion (1) | Eye lens (1) |
| Ezetimibe (2) | Fabaceae (2) | Facial Pain (1) |
| Factor analysis (1) | factorial design (5) | Factors (1) |
| Factors associated with medication non-adherence (1) | Falcipain-2 (1) | Family Planning Services (1) |
| Family satisfaction (1) | family therapy (1) | famotidine (2) |
| fast disintegrating tablet (1) | Fast Disintegrating Tablets. (1) | Fast dissolving film (1) |
| Fast dissolving films (1) | Fast dissolving tablets (1) | Fasting serum insulin level (1) |
| Fat (1) | Fatty acid profile (1) | FC reagent (1) |
| FDA AERS Database (1) | FDA Approval (1) | Fenugreek (1) |
| Ferric reducing antioxidant power assay (1) | Ferritin (1) | Ferrous sulfate (1) |
| Fetal Case Report (1) | Fialuridine', (1) | Ficus bengalensis (1) |
| Ficus bengalensis (Moraceae) (1) | Ficus racemosa (1) | film (1) |
| film hydration (1) | First permanent molars (1) | Fixed drug eruption (1) |
| Flavonoid (3) | Flavonoid Compounds (1) | Flavonoid fraction (1) |
| flavonoids (3) | Flavoxate HCl (1) | FlK-1 (1) |
| Floating beads (1) | floating controlled drug-delivery system (1) | Floating Drug Delivery (1) |
| Floating drug delivery system (1) | floating lag time (1) | Floating tablets (1) |
| Floriculture (1) | fluoroquinoes (1) | Fluoxetine (1) |
| Flupritine maleate (1) | flurbiprofen (1) | Flux (2) |
| FMCG (1) | folkloric use (1) | Follow up treatment (1) |
| Food drug and cosmetic act (1) | Forced degradation (4) | Forced degradation studies (1) |
| forced swim test (1) | Formication (1) | Formulary (1) |
| Formulary. (1) | Formulation (4) | Formulation and development (1) |
| Fourier transform infra red spectroscopic (1) | FPG (1) | FPGEE (1) |
| Fraction (1) | Franz Diffusion Cell (3) | free radical scavenger (1) |
| Free radicals. (1) | Freeze-drying (1) | Freund’s complete adjuvant (1) |
| Fructo-Oligosaccharide (FOS) (1) | Frusemide (1) | Frusemide-induced complications (1) |
| FTIR (5) | Fumes (1) | Fungal infections (1) |
| furosemide (1) | G6PD deficiency (1) | GABA (1) |
| Galacto-Oligosaccharide (GOS) (1) | Galic Acid (1) | gallic acid (3) |
| Galphimia glauca Clav (1) | Gamma irradiation (1) | Gangrenous (1) |
| Ganoderma lucidum (1) | Gap Junctions; Hypersynchronization; Pentylenetetrazole; Maximal Electroshock (1) | Garcinia daedalanthera extract (1) |
| Garcinia imberti (1) | Garcinia imberti bourd (1) | Garcinia indica (1) |
| Garcinia latissima (1) | gaseous contact (1) | gastric treatment (1) |
| Gastric ulcer (1) | Gastro-retentive drug delivery system (1) | gastroprotection (2) |
| gastroretentive (1) | gastroretentive drug delivery system (1) | Gatot Soebroto hospital. (1) |
| GC-MS (1) | GC-MS analysis (2) | GC-MS. (1) |
| GDP (1) | Gelatin (1) | Gelling Capacity. (1) |
| Gels (1) | Gemcitabine HCl (GCH) (1) | gemfibrozil (1) |
| Gender (1) | Gender and HIV. (1) | Gene expression (1) |
| Gene expressions (1) | Gene modification (1) | Gene silencing (1) |
| General medicine (1) | Generic (2) | generic drugs (2) |
| Generic medicines (2) | Generic name. (1) | Generic substitution (1) |
| Generics (1) | Genetic polymorphisms (1) | genetic Signature (1) |
| Genotoxin (1) | Genotype frequency (1) | Gentamicin (4) |
| gentamicin sulfate (2) | Geriatrics (3) | Gewald’s reaction (1) |
| GFAP (1) | Gibb’s reagent (1) | Gina criteria (1) |
| Ginger (1) | Gingival hyperplasia (1) | Gingival hypertrophy (1) |
| gingival pocket (1) | Gingival recession (1) | Gingival thickness (1) |
| Gladiolus segetum (1) | glibenclamide (4) | gliclazide (2) |
| Glidescore (1) | Glimepiride (2) | glimepride (1) |
| Glipizide (3) | glitazars (1) | Global education (1) |
| Global publications (1) | Glomerulonephritis (1) | Glucagon (1) |
| Glucocorticoids (1) | Glucosamine sulphate (1) | Glucose (1) |
| glucose tolerance test (1) | glutathione (1) | Glycemic Control (1) |
| Glycerin (1) | Glycerine (1) | Glycine max (1) |
| Glycosylated hemoglobin (HbA1c) (1) | Glycosylated hemoglobin A1c (1) | Gnetum gnemon (2) |
| Goal orientation (1) | Goldenhar syndrome (1) | good manufacturing practices (1) |
| Gotu kola leaves extract (1) | GPx (1) | Graft Rejection (1) |
| Graft Survival (1) | Grafting (1) | Grafts (1) |
| Gram negative (1) | Gram positive (1) | Grape seed extract (1) |
| Grape seed oil (1) | Grapes seed extract (1) | Gravimetry (1) |
| Grazing angle X-ray diffraction (1) | Green tea (1) | Green Tea Leaves Extract (2) |
| Grip strengthening test (1) | Griseofulvin (1) | GSH (2) |
| guanyl cyclase stimulator (1) | Guest Editorial (1) | Guidelines (1) |
| Gulf cooperation council (1) | Gum and fat fractions (1) | Gum arab (1) |
| Gymnema Sylvestre (2) | Gynura procumbens (1) | GYTS (1) |
| H+ (1) | H-460 (1) | H2 Receptor Antagonist (1) |
| H2O2 (1) | HAART (1) | Haematological (1) |
| Haemoglobin (1) | Haemolysis (1) | Haemolytic ratio. (1) |
| Hair dye. (1) | Hair Growth Activity (1) | Hair Tonic (1) |
| Hajj (1) | haloperidol (2) | Hand and Foot Syndrome (1) |
| hardness (1) | Haritaki (1) | harmacotherapy-based problems (1) |
| Harmonization (2) | Hazardous drugs (1) | HbA1C (2) |
| HBV (1) | HCT: Hydrocholrothiazide. (1) | HDAC4 (1) |
| HDAC7 (1) | head twitch (1) | Health benefits (1) |
| Health Care Costs (1) | Health care profession (1) | health care professionals (1) |
| health care students (1) | Health care. (1) | Health Expenditures (1) |
| Health Hazard (1) | Health informatics (1) | Health Information Technology (1) |
| Health Knowledge (1) | Health problems (1) | Health Professionals (1) |
| Health related quality of life (1) | Health Services Accessibility (1) | Health Status Indicators (1) |
| Healthcare (4) | healthcare communication (1) | Healthcare Delivery (1) |
| healthcare expenditure (1) | Healthcare Professionals (1) | healthcare providers (1) |
| Healthy volunteers (1) | heart failure (3) | Heart failure clinics (1) |
| Heat-shock (1) | Hematological parameters (1) | hematological toxicity (1) |
| Hematology (2) | Hematoma (1) | Hematopoietic progenitors (1) |
| Hemodialysis (2) | Hemoglobin (1) | Heparin (1) |
| hepatic impairment (1) | Hepatitis (1) | Hepatitis B (1) |
| Hepatitis B virus core protein (1) | Hepatocellular (1) | Hepatocurative (1) |
| hepatoprotective (2) | hepatoprotective activity (3) | Hepatotoxicity (1) |
| HER1 (1) | HER2 (1) | HER3 (1) |
| HER4 (1) | Herbal active ingredients (1) | Herbal drugs (1) |
| Herbal medications (1) | Herbal medicine (2) | herbal medicines (1) |
| Herbal therapy (1) | Herbaldb (1) | HET-CAM (1) |
| Heterocyclic compound (1) | Heterotopic Pregnancy (1) | Hex (1) |
| Hexane (1) | Hibiscus cannabinus Linn. (1) | Hibiscus rosa. (1) |
| High fat diet (2) | High Fat Diet Model (1) | High impact resin (1) |
| high performance liquid chromatography (1) | high performance thin layer chromatography (1) | High-density lipoprotein cholesterol (1) |
| High-fat diet (1) | high-performance liquid chromatography (2) | High-throughput screening (1) |
| Higher education (1) | highly active antiretroviral therapy (1) | Highly Cited Papers (1) |
| Himatanthus drasticus (1) | Hip Arthroplasty (1) | Hirsutism (2) |
| Histocompatibility. (1) | Histological studies. (1) | Histopathological studies (1) |
| Histopathology (2) | HIV (1) | HIV associated dementia. (1) |
| HIV-1 RT (1) | HIV-associated neurocognitive disorder (1) | HIV/AIDS Patients (1) |
| HL-60 and K-562 (1) | HLA (1) | HMG-CoA Reductase (1) |
| Homeopathic medicines (1) | Homeopathy (1) | homology modeling (1) |
| Honey (1) | Honeycomb (1) | Hordeum vulgare (1) |
| Hordeum vulgare hull (1) | Horticulture (1) | Hospital pharmacy (2) |
| hospitalized children (1) | hospitalized patients (1) | Hospitals (1) |
| host (1) | Host-guest interactions (1) | hot plate (1) |
| HP-ß Cyclodextrin complexes (1) | HPLC (9) | HPLC (High Performance Liquid Chromatography) Ornidazole (1) |
| HPLC method validation (1) | HPLC. (1) | HPMC (1) |
| HPMC capsules (1) | HPMC K100M (2) | HPMC K4M (1) |
| HPTLC (7) | HPTLC Fingerprinting (1) | HQLQ (1) |
| HRQoL (3) | HSV-1 (1) | Human breast cancer cells (1) |
| Human breast cancer MCF -7 cells (1) | human immunodeficiency virus (3) | human immunodeÞ ciency virus (1) |
| Human Papillomavirus (1) | Human plasma (2) | human plasma level (1) |
| Human plasma; Liquid chromatography–tandem mass spectrometry (LC–MS/MS); Method validation; Pharmacokinetics (1) | Humanitarian device exemption. (1) | Hydnocarpus Pentandra (1) |
| Hydralazine hydrochloride (1) | Hydroalcoholic (1) | hydrochlorothiazide (2) |
| Hydrochlorthiazide (1) | hydrogel (2) | Hydrogels (1) |
| hydrogen sulfide (1) | hydrogenated castor oil (1) | Hydrophilic drugs (1) |
| Hydrophillic sealants (1) | Hydrophobic sealants (1) | Hydrotrophy (1) |
| hydroxy propyl methyl cellulose (1) | Hydroxyapatite (1) | Hydroxyl radical (1) |
| hydroxypropyl cellulose (1) | hydroxypropyl methyl cellulose (2) | Hydroxypropyl methylcellulose (1) |
| Hydroxypropyl methylcellulose E15 (1) | Hydroxypropyl-β- cyclodextrin (1) | Hydroxypropylmethyl cellulose (1) |
| Hydroxypropylmethylcellulose (1) | Hyperactive orofacial musculature (1) | Hypercholesterolemia (1) |
| Hypercholestremia (1) | Hyperglycemia (1) | Hyperglycemic (3) |
| Hyperglycemic mice (1) | Hyperhomocystienemia (1) | Hyperlipoprotienemia(a) (1) |
| hyperoxaluria (1) | Hypersensitivity (1) | hypertension (7) |
| Hypertension( HTN) (1) | Hypertensive’s (1) | Hyperthyroidism (1) |
| hypertriglyceridemia (2) | Hypertrophy (1) | Hyperzincuria (1) |
| Hyphenated system (1) | hypoglycemic (1) | Hypoglycemic activity (1) |
| hypolipidemic (1) | Hypomineralization (1) | Hypothyroidism (1) |
| Hypozincaemia (1) | IBD (1) | IBD - Inflammatory Bowel Disease (1) |
| IC50 (2) | ICH (2) | ICH guidelines (3) |
| ICP22 (US1) gene (1) | IL-17 (1) | IL-6 (2) |
| IL-MAE (2) | Illiterate (1) | Iloperidone (1) |
| image analysis (1) | imidazole (1) | Immediate release layer and Bioavailability (1) |
| Immune response (1) | Immune suppression (1) | immunocytochemistry (1) |
| Immunoinformatics (1) | Immunological response (1) | Immunomodulatory (1) |
| Immunomodulatory effect (1) | Impacted (1) | Improving (1) |
| Impurity (1) | In silico (2) | in situ gelation (1) |
| in vitro (4) | In vitro kinetics (1) | In vitro penetration lotion (1) |
| In vitro penetration test (1) | In vitro Penetration Test. (1) | In vitro release (1) |
| In vitro–In vivo (1) | in vivo (1) | In vivo kinetics (1) |
| In-patien (1) | in-vitro dissolution study (1) | In-vitro skin permeation (1) |
| Inappropriateness (1) | Inclusion complex (1) | inclusion complexes (2) |
| indexed cost (1) | India (8) | India. (1) |
| Indian context (1) | Indian publications (1) | Indian Traditional medicine (1) |
| Indion 234 (2) | Indion resin (1) | indomethacin (2) |
| Indonesia (2) | Indonesian Herbal Database. (1) | Indonesian National Health Insurance (1) |
| Industry (2) | Inequality (1) | infarct size (1) |
| Infection prevention (1) | infective endocarditis (1) | infertility (1) |
| Infit and outfit indices (1) | inflammation (4) | inflammatory bowel disease (2) |
| Information need (1) | Information system (1) | Information Technology Officers (1) |
| Information tool (1) | Inhibitor MDM2 (1) | Inhibitory activity (1) |
| innovation ecosystems (1) | inorganic salts. (1) | INR (1) |
| inß ammation (2) | inß ammatory bowel diseases (1) | Insilico anticancer screening (1) |
| insulin (5) | Insulin receptor (1) | Insulin regimen (1) |
| insulin resistance (1) | Insulin resistance. (1) | insulin use in primary care (1) |
| Insulinophobia (1) | Integrase inhibitor (1) | Integrated Courses (1) |
| integrated economic analysis (1) | Intellectual Property l (1) | Intellectual property rights (1) |
| intelligent tutoring (1) | Intensive care unit (1) | Intensive Care Unit (ICU) (1) |
| Intensive Monitoring (1) | interaction (2) | interferon (1) |
| interleukins (1) | International Collaboration (1) | International HIV dementia scale (IHDS) (1) |
| international organization (1) | international organizations (1) | international trade (1) |
| Internet (1) | Internet pharmacy (1) | interpretation (1) |
| Interventional tool (1) | Interventions (1) | Intervertebral disc C4/5 and C5/6 (1) |
| Intracanal medicament (1) | Intranasal delivery (1) | intraocular presuure (1) |
| Intrauterine Pregnancy (1) | Intravenous (1) | inventory index (1) |
| inventory management (3) | Investigation (1) | investigators (1) |
| Invited Article (2) | Ion Gelation Method (1) | ion pair complex (1) |
| Ionic gelation (1) | Ionic liquid (3) | Ionic liquid- based microwave-assisted extraction (1) |
| ionic liquid-based microwave-assisted extraction (1) | Ionizing radiation (1) | ionotropic gelation (1) |
| iontophoresis (2) | Ipsilateral symptoms (1) | Iraq (1) |
| Iridoid glycoside (1) | iron chelation therapy (1) | Irrational (1) |
| Irrigation (1) | Irvingia gabonensis (1) | isatin (3) |
| ischemia (1) | ischemia-reperfusion injury (1) | Ischemic (1) |
| ischemic heart disease (1) | ISO (1) | isoniazid (3) |
| isonicotinohydrazide (1) | Isoprinosine (2) | Isopropyl myristate (1) |
| isoproterenol (1) | isoxazoline (1) | itopride HCl (1) |
| JNC 8 Guidelines. (1) | Journal (1) | Jurkat (1) |
| K+-ATPase β subunit (1) | K+ATP channel (1) | K-CAPS (1) |
| K562 (1) | Kaffir lime (1) | Kajjali (1) |
| Kalanchoe Pinnata (1) | KAP (2) | KAP study (1) |
| Kappa Concordant value (1) | Kappa. (1) | Karachi (2) |
| Kathakakhadiradi kashyam (1) | Kati chakrasana (1) | Kernel powder (1) |
| Ketamine (1) | Ketoprofen (1) | Ketorolac (1) |
| Ketorolac salt (1) | Key words: 5-FU (1) | Key words: Esomeprazole (1) |
| kidney (2) | Kidney Transplantation (1) | kinetic drug release (1) |
| Kinetic Modelling (1) | KMnO4 (1) | kneading method (1) |
| kneading technique (1) | knowledge (15) | Kumar’s score (1) |
| L-arginine (1) | L-Thyroxine (1) | L. acidophilus (1) |
| labeling (1) | Laboratory findings. (1) | Lactobacilli (2) |
| Lactobacillus (1) | Lag period (1) | Lagenaria siceraria (1) |
| Lantana camara (1) | Lantana montevidensis (1) | Larvacidal (1) |
| Laurence-Moon-Bardet-Biedl Syndrome (1) | Lawsone methyl ether (1) | LC-MS (1) |
| LC-MS/MS (1) | LC/MS/MS (1) | LC50 (1) |
| LCMS/MS (1) | LC–MS/MS (1) | LDL-C (1) |
| Leaf (1) | Learning process (1) | leaves (4) |
| Leftover medicines, (1) | Leg Length (1) | Leptin (1) |
| Letter to Editor (4) | Letter to the Editor (3) | Letters to the Editor (6) |
| Leucaena leucocephala (1) | Leucas lavandulaefolia (1) | Levocetirizine (1) |
| Levodopa (1) | Lexicomp (1) | Lichen planus (1) |
| Licofelone (1) | Ligand-based drug design (1) | Lightening (1) |
| Limb Length (1) | Limbs (1) | lime fruit (1) |
| Linagliptin (1) | Lindernia ciliata (1) | Linezolid (1) |
| Linoleic acid (1) | lipid matrix (1) | lipid metabolism (2) |
| lipid microspheres (1) | Lipid nanocrystals (1) | Lipid peroxidation (3) |
| lipid peroxides (1) | lipid profile (1) | Lipid profile membrane bound enzymes (1) |
| lipids (1) | lipoic acid (1) | liposome (1) |
| Lippia (1) | lithium toxicity (1) | Live-well™ (1) |
| liver function (2) | Liver necrosis (1) | Liver tonic (1) |
| Liver Transplantation (1) | Local drug delivery (1) | locomotor activity (1) |
| Low-density lipoprotein cholesterol (1) | Lozenges (1) | Luffa echinata (1) |
| Lumbar Spinal Stenosis (1) | Luminesce (1) | Lung (1) |
| Lung cancer (3) | Lupenoic acid (1) | Lupus (1) |
| Lycatab C (1) | Lympadenopathy (1) | lymphadenitis (1) |
| Lymphoma (1) | Lysozyme (1) | M. tuberculosis H37Rv (1) |
| Maceration (1) | Macromicroscopy study (1) | Macrophage cell line (1) |
| Mahkoside A (1) | Major Contributed Organizations (1) | Malaysia (5) |
| Malaysia. (1) | Malaysian. (1) | Male (1) |
| Maleic Acid (1) | Malignant transformation (1) | malondialdehyde (2) |
| Maltodextrin (2) | Mammary carcinoma (1) | Mandibular hypoplasia (1) |
| Mangiferin (1) | Mangosteen Peels (1) | manidipine dihydrochloride (1) |
| Mannich base (1) | Mannich Bases (1) | Marine fungi compounds (1) |
| Mast cell (1) | Maternal Care. (1) | Mathematical modeling (1) |
| matrix (1) | Matrix Tablet (1) | matrix tablets (3) |
| MCF-7 (1) | MDA (2) | MDR-TB (2) |
| mean age (1) | Mechanism (1) | mechanisms (1) |
| Meclizine HCl (1) | Medical (1) | Medical and non-medical (1) |
| medical costs (1) | Medical device (1) | Medical device recalls (1) |
| medical errors (1) | Medical informatics (1) | Medical Inpatients (1) |
| Medical practitioner (1) | Medical Representative (1) | Medical Respresntative (1) |
| Medical sales representative (1) | Medical students (2) | medication adherence (5) |
| medication adherence behaviour (1) | medication error (2) | Medication errors (1) |
| Medication non-adherence (1) | Medication reconciliation (1) | Medication regimen complexity (1) |
| medication safety (1) | Medication taking (1) | Medication understanding (1) |
| medication-/drug-related problem (MRP/DRP) (1) | Medicinal ornamental plants (1) | Medicinal plant (1) |
| Medicinal plants (4) | Medicine (2) | Medicine consumers (1) |
| Medicine disposal (1) | medicine-use practices (1) | Medicines storage (1) |
| Medicines wastage (1) | Mediterranean diet (1) | Melanesia (1) |
| Melastoma malabathricum (1) | Melinjo (2) | Meloxicam (1) |
| Memory (2) | Memory and learning. (1) | Men (1) |
| Menaquinone-4 (1) | Menstrual cycle (1) | Mental health (1) |
| Mental health services. (1) | Mentha arvensis (1) | mesalamine (1) |
| Metabolic ratio (1) | Metabolic syndrome (1) | Metabolism (1) |
| Metabolite profiling (1) | Metabomics (1) | metagenomic (1) |
| metformin (7) | metformin hydrochloride (1) | Methanol (1) |
| methanolic extract (1) | methocel (2) | method development (4) |
| Method optimization (1) | method validation (4) | Method validation Valsartan (1) |
| Methotrexate (1) | methyl orange (1) | methyl-b cyclodextrin (1) |
| metoprolol tartarate (1) | MetS (1) | Mevalonate (1) |
| Micro emulsion (2) | Micro particles. (1) | Micro-emulsion (1) |
| microbial contamination (1) | Microbiological (1) | Microbroth dilution (1) |
| Microcapsules (1) | microcrystalline cellulose (5) | microdilution (1) |
| Microdosing (1) | Microemulsion (1) | Microencapsules (1) |
| microneedles (1) | Micronucleus assay (1) | microparticles (1) |
| microsphere (1) | Microsphere Phytosome (1) | microspheres (6) |
| microtriches (1) | Microwave assisted extraction (1) | Microwave-Assisted Extraction (2) |
| miglitol (1) | Migraine (2) | migraine management, (1) |
| Mild neurocognitive disorder (1) | Milk (1) | Milnacipran (1) |
| Mimosa pudica (1) | Mineral trioxide aggregate (1) | minimal inhibitory dose (1) |
| Minimum Inhibitory Concentration (MIC) (1) | mismatches (1) | mitochondria (1) |
| Mix mode (1) | MLR (1) | MMAS-8 - Modified Morisky Adherence Scale-8 (1) |
| Modafinil (1) | Modeling (1) | modern medicine (1) |
| modified melt dispersion technique (1) | Modified Starches (1) | MODY (1) |
| Mol inspiration (1) | Molar Incisor (1) | Molecular characterization (1) |
| Molecular docking (10) | molecular docking and anti cancer activity. (1) | Molecular Docking. (1) |
| Molecular Dynamic (1) | Molecular dynamics (3) | Molecular Dynamics Simulations (1) |
| Molecular Imprinted Polymer (1) | Molecular mimicry (1) | Momordica charantia (1) |
| Momordicin II Natural Products (1) | monoamine oxidase B (1) | Monocots (1) |
| Monophyletic (1) | montelukast (2) | montelukast sodium (1) |
| Montelukast, (1) | moraceae (1) | Morbidity (1) |
| Morin and validation (1) | Moringa oleifera (3) | Moringa oleifera. (1) |
| Morisky medication adherence questionnaire (1) | Morocco (1) | Mortality (4) |
| Morus alba (2) | Mosquito repellent (1) | Mouth Dissolving Tablets (1) |
| mouth-dissolving film, (1) | MPO activity (1) | MPTP (1) |
| MTT Assay (2) | MTT method (1) | MUC2 (1) |
| MUC6 (1) | Mucoadhesive (1) | Mucoadhesive agent (1) |
| mucoadhesive formulation (1) | Mucoadhesive Oral In situ gel (1) | mucoadhesives (1) |
| mucodhesive (1) | Mulberry (1) | multi granules (1) |
| Multi Organ Failure (1) | multidrug resistant pathogens (1) | Multikinase Inhibitor (1) |
| multiparticulates (1) | multiparticulates dosage form (1) | Multiple myeloma (1) |
| Multiple Organ Dysfunction Syndromes (MODS) (1) | Multiple Organ Failure (1) | multiple regression (1) |
| multiple regression analysis (1) | Multitargeted drug (1) | Murraya koenigii L.Sprengel S.mutans (1) |
| Mycobacterium tuberculosis. (1) | Mycophenolate mofetil (1) | Mycophenolic acid (1) |
| Myeloperoxidase (1) | myocardial infarction (2) | Myomectomy. (1) |
| Myrica esculenta (1) | Myristicin (1) | Myrobalan (1) |
| N-aminoimidazoles (1) | N-napthyl ethylene diamine dihydrochloride (1) | Na+/K+-Atpase (1) |
| NABP (1) | NACO. (1) | Nadi shuddhi pranayama (1) |
| Naftopidil (1) | Naltrexone (1) | nano size (1) |
| Nanoemulsion (1) | Nanoformulation (2) | nanoformulations (1) |
| Nanonization. (1) | Nanopacticle (1) | Nanoparticle (2) |
| Nanoparticles (11) | Nanosuspension (1) | Nanosuspension tablets (1) |
| Nanosuspensions (1) | Naphthoquinone derivative (1) | NAPLEX (1) |
| naproxen (1) | Naranjo (1) | Naranjo algorithm (2) |
| Naranjo algorithm. (1) | Naranjo’s ADR probability scale (1) | Narikel Lavan (1) |
| Narrow therapeutic index drugs (1) | Nasal delivery (1) | Nasal gel (1) |
| Nateglinide (1) | National Fomulary (1) | National Formulary (2) |
| National Health and Morbidity Surveys (1) | National Policy of Pharmaceutical Assistance (1) | National Public Health Programs (1) |
| Natural (1) | natural compounds (3) | Natural deep eutectic solvent (1) |
| Natural Polymers (1) | natural products (3) | NCC-PvPI; Hepatitis B vaccine; ADR/AE; VigiFlow; system organ class (SOC) (1) |
| Nebivolol (2) | nebivolol hydrochloride (1) | Necrosis. (1) |
| need assessment (1) | Nephropathy (1) | Nephroprotective (3) |
| Nephrotic syndrome (1) | Nephrotoxicity (1) | Nerium indicum (1) |
| neuropathy (1) | Neuroprotection (1) | Neuroprotective (1) |
| Neurosurgical (1) | neutropenia (1) | nevirapine (1) |
| new molecule (1) | Newborns (1) | Nicorandil (1) |
| Nicotine (1) | Nicotine dependence (1) | Nifedipine. (1) |
| Nigeria. (1) | nigrostriatal pathway (1) | Nil (12) |
| Nill (19) | Nimesulide (1) | niosome (1) |
| Niosomes (1) | Nitric acid (1) | Nitric oxide (3) |
| Nitrogen starvation (1) | NK cell (1) | NMDA (1) |
| NMDA receptors (1) | Noccik Kudinir (1) | Nodular skin lesions (1) |
| Non-linear (1) | non-prescription medicine use (1) | Non-steroid anti-inflammatory (1) |
| Non-steroidal anti-inflammatory drugs (1) | Non-surgical endodontic therapy. (1) | nonamers. (1) |
| noncommunicable disease (1) | noncompliance (1) | Nonionic surfactants (1) |
| Nonomuraea longicatena (1) | nootropic (1) | Norfloxacin (1) |
| Normoglycemic rats (1) | northeast India (1) | Nose to brain delivery (1) |
| Nosocomial infections (1) | Nothopanax scutellarium (1) | Novel delivery (1) |
| NSAIDs (1) | Nuclear medicine (1) | nuclear pharmacy (1) |
| Nucleo CMP (1) | Nude mice (1) | Nutmeg oil (1) |
| Nutraceuticals (1) | Nutrient starvation (1) | Nutrition (1) |
| Nystagmus Phenytoin toxicity (1) | O-Phenylene diamine (1) | Obesity (4) |
| Occupational health (1) | Ocimum gratissimum (1) | Odontopediatric (1) |
| Off-label (1) | offending drugs (1) | Okra Mucilage (1) |
| Olmesartan (1) | olmesartan medoxomil (1) | Omega-6 fatty acid (1) |
| Omeprazole. (1) | Omics (1) | Oncology. (1) |
| Oncopharmacists (1) | ondansetron (3) | ondansetron hydrochloride (1) |
| Online health screening (1) | Online pharmacies (1) | OPD – Outpatient Department. (1) |
| open field (1) | Ophthalmic (1) | ophthalmic delivery (1) |
| ophthalmic inserts (1) | Opinion (1) | Opportunities (1) |
| Opportunity (1) | Optimal stress (1) | optimization (9) |
| Oral bacteria (1) | Oral cancer (2) | Oral disease (1) |
| Oral diseases (1) | oral disintegrating tablets (1) | Oral glucose tolerance (1) |
| oral glucose tolerance test (3) | Oral hypoglycemic drugs (1) | oral insulin (1) |
| Oral manifestations (1) | Oral Medicine (1) | Oral Rehabilitation (1) |
| Oral route (1) | Oral Surgery (2) | Orally disintegrating tablets (1) |
| Organ Toxicities (1) | organic acids (1) | organogel (1) |
| Organophosphate (1) | ORIF (1) | Origanum vulgare (1) |
| Original Article (3) | Originator. (1) | Orlistat (2) |
| orodispersible tablet (1) | orodispersible tablets (2) | Oscillopsia (1) |
| Osmotic pump (1) | Osseointegration (1) | Osteoarthritis (2) |
| Osteoblast (3) | Osteoclast (2) | OTC switch (1) |
| Otomycosis (2) | Outcome therapy (1) | Outdoor patients (1) |
| Outpatient Pharmacy (1) | Outpatients (1) | ovalbumin (1) |
| Ovarian (1) | Ovarian Cyst (1) | Over the counter (1) |
| Over-the-counter (1) | Overweight (1) | OVX (1) |
| Oxalic acid (1) | oxazepinone (1) | oxcarbazepine (1) |
| Oxidation (1) | oxidative damage (1) | oxidative stress (6) |
| Oxyresveratrol (2) | oxytetracycline (1) | P-dimethylaminobenzaldeyde (1) |
| P-drug. (1) | P-drugs (1) | P-glycoprotein (1) |
| P. dulce (Fabaceae) (1) | p21SNFT (1) | p53 tumor suppressor gene (1) |
| Package insert (1) | Paediatric (2) | Paediatrics (1) |
| Pain (2) | Pain scale (1) | Pain. (1) |
| Painkiller (1) | pair wise procedures (1) | Pakistan (2) |
| Pakistan. (4) | Paliperidone palmitate (1) | Pancreatitis. (1) |
| Pantoprazole (1) | papain (1) | Papain. (1) |
| PAR-2 receptor (1) | para-diaminobenzaldehyde (1) | paracetamol (4) |
| Paracetamol. (2) | Paresis (1) | Parkinson’s disease (2) |
| partial least square (1) | particle size analysis (1) | PASS (1) |
| passive avoidance learning (1) | Patch (1) | patents (4) |
| Pathological response (1) | Patient (2) | Patient adherence. (1) |
| Patient Care (1) | patient counseling (1) | Patient counseling and Patient information leaflet (1) |
| patient education (2) | Patient health questionnaire (PHQ) (1) | Patient Safety (2) |
| Patient satisfaction (1) | Patient Satisfaction Questionnaire (1) | Patient Survival (1) |
| patient-physician communication (1) | Patient-safety (1) | patients (4) |
| Patients. (1) | paw edema (1) | Paw edema. (1) |
| Paw volume (1) | PE 18:0/18:0-PEG 2000 (1) | Pectin (1) |
| pedagogy (1) | Pediatric (3) | Pediatric cancer (1) |
| Pediatric Dentistry (1) | Pediculosis (1) | Pegagan extract (1) |
| PEGylation (1) | Pemphigus vulgaris (1) | Penang (1) |
| penetration (3) | penetration enhancer (1) | penetration pressure (1) |
| penicillamine (1) | Penicillins (1) | pentylenetetrazole (1) |
| PEO (1) | Peperomia pellucida (L) Kunth (1) | Peperomia pellucida (L.) Kunth (3) |
| Peppas and Higuchi’s equations (1) | Peptic Ulcer. (1) | peptide vaccine (1) |
| Peptidoglycan (1) | percentage healing of wound area (1) | perception (8) |
| Periauricular tags. (1) | pericyclic fiber (1) | Periodontal disease (1) |
| periodontal diseases (1) | Periodontal dressing (1) | periodontal pocket (1) |
| Peripheral Neuropathy (1) | Permanent (1) | Permeation (3) |
| Permeation enhancer (1) | Peroxisome proliferator-activated receptorg (PPAR-γ) agonists (1) | Persistent ulcer (1) |
| Personal care products (2) | Persons and items reliability (1) | pH dependent approach (1) |
| pH independence (1) | pH-sensitive (1) | Phaleria marcocarpha (1) |
| Pharm. D. Integrated (1) | Pharm. D. Post Baccalaureate. (1) | pharma counseling (1) |
| pharmaceutical (1) | pharmaceutical advertisements (1) | Pharmaceutical care (2) |
| Pharmaceutical Care service (1) | pharmaceutical care. (1) | pharmaceutical formulations (1) |
| Pharmaceutical Industry (1) | Pharmaceutical Marketing (1) | Pharmaceutical Services (2) |
| Pharmaceutical-Care (1) | Pharmaceutical-industries (1) | Pharmacist (4) |
| Pharmacist intervention (1) | Pharmacist intervention. (1) | pharmacist role in public health (1) |
| Pharmacists (2) | pharmacists India (1) | Pharmaco epidemiology (1) |
| Pharmacodynamic (3) | Pharmacodynamic activity (1) | pharmacodynamics (2) |
| Pharmacogenetics (1) | Pharmacogenomics (1) | Pharmacognostic (1) |
| pharmacognostic standardization (1) | pharmacognostical (1) | Pharmacognosy (1) |
| pharmacognosy study (1) | Pharmacokinetic (7) | Pharmacokinetic interactions. (1) |
| pharmacokinetics (9) | Pharmacokinetics. (2) | Pharmacological properties (1) |
| Pharmacophore (3) | Pharmacosomes (1) | Pharmacovigilance (17) |
| Pharmacovigilance Programme of India (1) | Pharmacovigilance. (1) | Pharmacovigilante’s (1) |
| Pharmacovigillance (1) | pharmacy (6) | pharmacy curriculum (2) |
| Pharmacy education (1) | Pharmacy Enforcement Division (1) | Pharmacy informatics (1) |
| Pharmacy intervention (1) | Pharmacy services (1) | Pharmacy store (1) |
| Pharmacy student (1) | Pharmacy students (1) | Phase diagrams (1) |
| Phase I studies (1) | Phase rule (1) | phase solubility (1) |
| phase solubility profile (1) | Phenobarbitone (1) | Phenolic (1) |
| phenolic compounds (2) | Phenolic content (1) | phenolics (1) |
| phenols (1) | Phenothiazine (1) | Phenytoin (4) |
| Phenytoin cold cream (1) | Phenytoin Toxicity (1) | Pheritima posthuma (1) |
| Phleboliths (1) | Phoenix dactylifera (1) | Phosphorylase kinase (1) |
| Photoprotection. (2) | Phthalates (1) | Phyllanthus emblica, (1) |
| Phyllanthus reticulatus (1) | Phylogenetic tree (1) | Phylogeny (1) |
| Physical activity (1) | Physical fitness (1) | Physical stability (1) |
| Physichochemical Characterization (1) | Physicians (5) | Physicochemical (1) |
| physicochemical evaluation (1) | physicochemical properties (1) | physiochemical descriptor (1) |
| Physiological role (1) | Phytochemical (2) | phytochemical prospection (1) |
| Phytochemical screening (1) | Phytochemicals (1) | Phytomolecule (1) |
| Phytopharmaceutical drug (1) | Phytosome (1) | picrotoxin (1) |
| pictograms (1) | Pilgrims (1) | PIM (1) |
| Pinus merkusii (1) | pioglitazone (1) | piperazine citrate (1) |
| Piperidino thiophene (1) | Piperine (2) | Piroxicam (2) |
| Pits and Fissures (1) | Pixel intensity. (1) | Plackett-Burman (1) |
| Plackett-Burman design (1) | plant extracts (1) | plasma (3) |
| Plasma concentration (1) | plasma concentrations (1) | Plasma creatinine (1) |
| Plasma insulin (1) | Plasma urea (1) | plasma-brain correlation (1) |
| Plasma. (1) | Plasmodium falciparum 3D7 (1) | Plasmodium falciparum. (1) |
| Platelet aggregation. (1) | Platelet rich fibrin membrane. (1) | Pleiotropic effects (1) |
| PLGA (1) | PLS (1) | PLSR (1) |
| Pluronic F 127 (1) | PM6 (1) | PM7 (1) |
| Pneumonia (2) | Point-measure correlation coefficients (1) | Poison (2) |
| Poisoning pattern (1) | Polarography (1) | Poloxamer 188 (1) |
| Poloxamer 407 (2) | Poloxamer 407. (1) | poly (lactic-co-glycolic acid) (1) |
| Poly herbal (1) | poly(ε-caprolactone) (1) | Poly-herbal (1) |
| polycaprolactone (1) | Polycystic Ovary Syndrome (1) | Polyelectrolyte complex (PEC) (1) |
| PolyElectrolytecomplex (1) | Polyethylene glycol (1) | Polyherbal (1) |
| polyherbal formulation (3) | Polymer (1) | Polymeric nanoparticles (3) |
| Polymorphism (1) | polypharmacy (7) | polypharmacy in diabetes mellitus. (1) |
| polyphenols (1) | Polysaccharide (1) | polyvinyl alcohol (2) |
| polyvinyl pyrrolidone (1) | Polyvinylpyrrolidone (1) | Polyvynil pyrrolidone (1) |
| Pomalidomide (1) | PON1 mRNA (1) | porosity (1) |
| Port-A Catheter. (1) | Portfolio (1) | Positive and Negative stressors (1) |
| Positive coping strategies. (1) | Posology (1) | Possible mechanisms (1) |
| Post marketing (1) | Post-antibiotic era (1) | Posterior reversible encephalopathy syndrome (1) |
| Potassium (1) | Potassium Channel (1) | Potassium chloride (1) |
| Potassium Nitrate (1) | Potential Drug-Drug Interaction (1) | Powder (1) |
| PPAR agonists (1) | PPARγ agonists. (1) | PPBG (1) |
| pPharmacokinetics (1) | PPP model (1) | practice (4) |
| practices (1) | pravastatin (1) | Pre ADMET (1) |
| pre prandial (1) | Pre University students (1) | Pre-authorization (1) |
| Prebiotic (2) | Precipitation (1) | precise (1) |
| Precision (1) | Predictors (1) | Pregabalin (1) |
| Pregnancy (3) | preliminary screening (1) | Premna esculenta (1) |
| prescriber (1) | Prescribing (2) | Prescribing errors (1) |
| Prescribing indicators (1) | Prescribing pattern. (1) | Prescription (3) |
| Prescription audit (1) | Prescription error. (1) | prescription monitoring (1) |
| prescription only medicines (1) | Prescription pattern (3) | Prescription refill (1) |
| Prescription review (1) | pressure dependent approach (1) | Prevalence (4) |
| Prevention. (1) | Price variation (1) | Primary health care (2) |
| Primary Health Care. (1) | Primary tooth (1) | Principal component analysis (1) |
| principal component regression (1) | Pristane (1) | Private Medical College (1) |
| PRO (1) | Probable (1) | Probiotic (1) |
| Probiotics (1) | Problem-based learning (1) | process capability (1) |
| Process parameters. (1) | Product Surveillance (1) | Products with Antimicrobial Action. (1) |
| progesterone (1) | Proniosomal gel (1) | Property Intellectual (1) |
| Prophylaxis (2) | propolis (3) | Proportional reporting ratio (1) |
| propranol hydrochloride (1) | Propranolol hydrochloride (1) | Prospection (1) |
| Prospective Study (2) | prostaglandins (1) | Prosthesis Coloring (1) |
| Proteasome activity (1) | protein proÞ le (1) | proteolytic enzymes (1) |
| Proton adduct (1) | Proton Pump Inhibitor (2) | Proton-pump Inhibitors (1) |
| Protransfersome (1) | Prteomics (1) | Pseudo ternary phase diagrams (1) |
| Pseudomonas aeruginosa (1) | Psidium Guajava (1) | Psychological mindedness (1) |
| Psychomotor (1) | Psychosis (2) | Psychotropic drugs (1) |
| Psychotropics (1) | Pterocarpus indicus (1) | Pterocarpus indicus Willd (1) |
| Public behavior (1) | Public health hospital (1) | Public hospital (2) |
| Public Service (1) | Publication (1) | Publications (2) |
| Pulmonary Fibrosis (1) | pulmonary hypertension (1) | Pulmonary toxicity (1) |
| Pulpectomy (1) | Pulse wave velocity (1) | Punica granatum (1) |
| Pyrazinamide (1) | pyrazine (1) | pyrazoline (1) |
| pyrazolines (2) | Pyrimidine (1) | Q1F (1) |
| QOL (1) | QSAR (3) | qualitative (1) |
| Qualitative analysis (1) | qualitative study (1) | Quality (1) |
| quality assurance (1) | Quality by design Ritonavir (1) | Quality Control (1) |
| Quality Indicators (1) | quality of internet information (1) | quality of life (7) |
| quantitative structure-activity relationship (1) | Quercetin (2) | Questionnaire (2) |
| quinazolin-4(3H)one (1) | quinazolinone (1) | Quinazolinone. (1) |
| quinoline derivatives (1) | R2 values (1) | Rabbit plasma (1) |
| Rabbits. (1) | radical scavenger (1) | radicals (1) |
| Radiculopathy (1) | Radio-mitigation (1) | Radiology Unit (1) |
| radiopharmaceuticals (1) | radiopharmacy (1) | Radioprotective (1) |
| Raillietina echinobothrida (1) | raloxifene hydrochloride (1) | Raltegravir potassium (1) |
| Raman spectroscopy (2) | ramipril (2) | ranitidine (1) |
| Ranitidine hydrochloride (2) | Ranitidine’. (1) | ranolazine (1) |
| Ransmission electron microscopy (1) | Rapid disintegration (1) | Rasagiline mesylate (1) |
| Rat (1) | ratio test procedures (1) | Rational pharmacotherapy. (1) |
| Rational prescribing (1) | Rational Use (1) | Rational use of Medication (1) |
| Rational use of medicine (1) | rational use of medicines (1) | rats (1) |
| Rattus novergicus (1) | Re-emerging viral infections (1) | re-precipitation (1) |
| recognized standards (1) | recovery studies (1) | Red ginger (1) |
| Reduction (1) | Reflective pedagogy paradigm (1) | reforms (1) |
| Regeneration (1) | Regression analysis (2) | Regressions statistics (1) |
| Regulation (1) | Regulations (1) | regulatory (2) |
| Regulatory affairs (1) | regulatory system (1) | Rehospitalisation (1) |
| Relative performance (1) | release kinetics (3) | Release studies. (1) |
| relese kinetics (1) | Removable denture (1) | Renoprotection (1) |
| Renoprotective (1) | repaglinide (2) | reperfusion (1) |
| Repurposing (1) | research (1) | Research Skills. (1) |
| reserpine (1) | Resident doctors (1) | Resistance (5) |
| Resistant starch (1) | Resource poor setting (1) | Respiratory tract (1) |
| Response Surface Methodology (3) | Response surface methodology. (1) | Response to antiretroviral therapy (1) |
| Resveratrol (2) | retail pharmacy (1) | Retention. (1) |
| Retinopathy (1) | retrospective cohort (1) | Retrospective study (2) |
| reversed-phase chromatography (1) | Rhabdomyolysis (1) | Rhaphidophora pinnata (1) |
| Rheumatology (1) | rhizomes (1) | Riboflavin (1) |
| Rice Bran Oil (1) | Rifampicin (2) | Ringer’s dextrose (1) |
| Ringer’s lactate. (1) | Riociguat (1) | Risk Estimation Matrix (1) |
| Risk factor. (1) | Risk factors (5) | Risk Factors. (1) |
| Risk rating (1) | Rituximab (1) | rivastigmine (1) |
| RNA interference (1) | RNAi (1) | RNAi technology (1) |
| RNTCP (2) | Rodenticides (1) | root (1) |
| Root canal filling materials (1) | Root canal infection (1) | Roots extract (2) |
| Ropinirole (1) | rosuvastatin (2) | rosuvastatin calcium (1) |
| Rota rod test (1) | Royal Malaysian Custom Officer (1) | RP-HPLC (8) |
| RP-HPLC method (1) | RP-TLC/Densitometry (1) | RP-UFLC method (1) |
| RT-qPCR (1) | Rubus fraxinifolius (1) | Rubus rosifolius (1) |
| rupatadine (1) | rutin (1) | ß avonoids (2) |
| S. mutans (1) | S.salivarius (1) | S.sanguis (1) |
| Saccharin (1) | Safe handling guidelines (1) | Safety (1) |
| Safoof razyanaj (1) | Safoof-e- Binai (1) | Sage (1) |
| Sambung nyawa (1) | Saponin (2) | saponins (1) |
| Sappan wood (1) | Saraschandra (1) | Satisfaction (1) |
| Saudi Arabia (7) | Saudi National Pharmacovigilance Centre (Saudi NPC) (2) | Saussurea (1) |
| Saussurea lappa (1) | scanning electron microscopy (3) | Schizophrenia (2) |
| Scientific Advertisements (1) | Scientometrics (5) | sclerotherapy (1) |
| Scopolamine (1) | Scores. (1) | Se- DeM ODT Expert system (1) |
| Second-line agents (1) | Secondary Level (2) | Sedation (1) |
| Sedation in pediatric patients (1) | Sedation scale (1) | seizure outcome (1) |
| Seizures (1) | Selected area electron diffraction (1) | Self efficacy. (1) |
| Self medication (1) | self-emulsifying drug delivery system (1) | Self-Harm (1) |
| self-medication (6) | Self-Nano Emulsifying Drug Delivery System (SNEDDS) (1) | self-nanoemulsification (1) |
| Selfmedication (1) | Semi-permanent hair dye (1) | senna spectabilis (1) |
| Sensitive (1) | sensory cortical activity. (1) | separation (1) |
| sepbox (1) | Septic shock (1) | Sequences distillation (1) |
| Sequential optimization (1) | Serum (1) | Serum Ferritin (1) |
| Serum Glutamate-Pyruvate Transaminase (1) | Serum Glutamic Oxaloacetic Transaminase (1) | Serum triglyceride (1) |
| Serum Vitamin D (1) | Serum. (1) | sesame oil (1) |
| severe febrile neutropenia (1) | Severe Neck Pain (1) | Severe sepsis (1) |
| Severity (2) | Sexual dysfunction in diabetes (1) | SF-36 (1) |
| Shodhana (1) | Short Communication (3) | short-term memory (1) |
| Sida rhomboidea.Roxb (1) | Side effect (1) | signal detection (1) |
| Signal detection. (1) | Signs and Symptoms (1) | Signs and Symtoms (1) |
| Silver nanoparticles (1) | silymarin (1) | Similarity factor (1) |
| similarity factor (f2) (2) | simplex lattice (1) | Simplex Lattice Design (2) |
| simultaneous determination (2) | simultaneous extraction (1) | simvastatin (1) |
| simvastatin. (1) | Single nucleotide polymorphism (1) | sintering (1) |
| siRNA (1) | siRNA. (2) | SIRT1 (1) |
| Sirtuin (1) | Sitagliptin phosphate (1) | six sigma (1) |
| SJS (1) | Skin diseases (1) | Skin drug test (1) |
| Skin protection (1) | Skin whitening (1) | SLAM markers (1) |
| SLS (1) | Smix (1) | Smix. (1) |
| Smoking (1) | smoking cessation. (1) | Smoking. (1) |
| smooth muscle cells (1) | Snake bite (1) | SNEDDS (2) |
| sobatum (1) | Social Media (1) | Social sexual. (1) |
| Sociodemographic factors (1) | Socioeconomic status (1) | SOD (1) |
| Sodium (1) | sodium alginate (1) | sodium alginate. (2) |
| sodium carboxy methyl cellulose (1) | sodium starch glycolate (3) | Sodium starch glycolate (SSG) (1) |
| Sodium Valproate (1) | Sofosbuvir (1) | Solanum nigrum (1) |
| Solanum trilobatum (1) | Solanum viarum (1) | Solanum xanthocarpum, (1) |
| Solasodine (1) | solid dispersion (5) | solid lipid nanoparticles (1) |
| Solid lipid nanoparticles. (1) | Solid Phase Extraction (1) | solubility (7) |
| Solubility enhancement (1) | Solubility. (1) | solvent casting (1) |
| solvent evaporation (4) | Solvent evaporation. (1) | sonication time (1) |
| sonophoresis (1) | Sorafenib (1) | Spacedrepetition. (1) |
| spasmolytic (1) | speciÞ city (1) | Spectrometric (1) |
| spectrophotometry (2) | sperm count (2) | SPF (1) |
| Spiro compounds (1) | Spleen colony assay (1) | Spondylosis (1) |
| Sponge implantation (1) | sponge implantation assay (1) | sponsors (1) |
| Spontaneous-Reporting. (1) | Sprague Dawley (1) | spray drying (1) |
| SPSS 20. (1) | ST segment elevation (1) | stability (1) |
| stability indicating (1) | stability indicating and validation. (1) | Stability indicating assay (1) |
| Stability indicating assay method (1) | stability indicating method of artemether (1) | stability indicating. (1) |
| Stability of the physical properties (1) | Stability test (1) | stability. (1) |
| stain removal (1) | stakeholders (1) | Standardization (6) |
| Standardized Zscore (1) | Staphylococcus aureus (1) | Staphylococcus sciuri (1) |
| Starlac (1) | Statin pathway (1) | Statins. (1) |
| Statistical Modeling (1) | Statistical optimization (1) | Stelechocarpus burahol (1) |
| Stem bark extract (1) | Stephania hernandifolia (1) | Stereospermum suaveolens (1) |
| Stereospermum tetragonum (2) | Sterilization Procedures (1) | Steroidal alkaloid (1) |
| Steudnera colocasiifolia (1) | Stevens-Johnson syndrome (1) | Stilbene (1) |
| Stimulantia (1) | Stimuli (1) | Stomatitis under prosthesis (1) |
| Strabismus surgery (1) | Streptococci (1) | Streptococcus mutans (3) |
| Streptokinase (1) | Streptomonospora arabica (1) | Streptomyces (1) |
| Streptozotocin (2) | Streptozotocin (STZ) (1) | streptozotocin-induced diabetes (1) |
| Streptozotocin. (1) | stress (3) | Stress degradation (1) |
| stress studies (2) | stroke and cardiac pacemaker. (1) | Stroke prevention (1) |
| structural descriptor (1) | Structured Communication. (1) | Stryphnodendron rotundifolium (1) |
| students (3) | students’ residence (1) | Sub Clinical Hypothyroidism. (1) |
| Sub-acute Inflammation (1) | Subcutaneous fat (1) | sublingual films (1) |
| substituted acetophenones (1) | Succinic acid (1) | sucrase (1) |
| Sudan (1) | Sulfated polysaccharides (1) | Sulfonylurea (2) |
| Sulfonylureas (1) | Sulphorhodamine-B (1) | Sun (1) |
| sun protection factor (2) | Sunlight (1) | Sunscreens. (1) |
| Super disintegrants (1) | superdisintegrants (2) | Superdisintergrants (1) |
| Superoxide Dismutase. (1) | superoxidedismutase (1) | superporous hydrogel composite (1) |
| Supply Chain Management (1) | support staff. (1) | Surface properties (1) |
| surfactant (1) | surfactants (2) | Surgery (2) |
| Surgical cutters (1) | surgical prophylaxis. (1) | Surgical. (1) |
| Survey questionnaire (1) | survey. (1) | Survival rate (1) |
| sustained release (3) | sustained release pellets (1) | sustained release. (1) |
| Susutained release layer (1) | Sweet orange peel extract (Citrus sinensis) (1) | swelling index (2) |
| swelling studies (1) | SWOT (1) | Symptoms (1) |
| Symptoms domain (1) | Synchronous spectrofluorimetry. (1) | Synergism. (1) |
| Synthesis (3) | Synthesis; 1-allyl-3-benzoylthiourea; COX-2; Analgesic; Lead Compound; (1) | Systematic review (1) |
| Systematic Review. (1) | Systemic steroids. (1) | Systems biotechnology (1) |
| Systolic dysfunction. (1) | T cell epitope (1) | T lymphocytes (1) |
| T regs (1) | Tab. Pardopa (1) | Tablet Compression (1) |
| Tacrolimus (1) | Tacrolimus Once Daily (1) | Tacrolimus Twice Daily. (1) |
| Tactile stimulation (1) | tail suspension test (1) | Tamarindus indica (1) |
| Tamilians (1) | Tamoxifen (1) | Target delivery (1) |
| Targeted drug delivery system (1) | taste masking (2) | tasteless complex (1) |
| taxane (1) | Taxanes (1) | Taxus baccata (1) |
| Teaching Hospital (1) | Technology (1) | technology-enhanced learning (1) |
| Tecoma stans (1) | tegument (1) | telmisartan (1) |
| Temporomandibular Joint (1) | Temporomandibular Joint Disoders (1) | TEN (1) |
| Tenatoprazole sodium (1) | Tenofovir disoproxil fumarate (1) | Tephrosia purpurea ethanolic seed extract (TpEt). (1) |
| Terminala bellerica (1) | Terminalia bellirica (1) | Termineliachebula;Plants; Galls;Albendazole; anthelmintic; Drug. (1) |
| Ternary phase diagram (1) | terpenoids (1) | Tertiary Care (1) |
| Tertiary care hospital (3) | testicular damage (1) | testosterone (3) |
| Tetrapreniltoluquinone (1) | thalassemia major (1) | therapeutic angiogenesis (1) |
| therapeutic dose (1) | therapeutic drug monitoring (2) | therapeutic effectiveness (1) |
| Therapeutic Policies (1) | Thermoreversible gel (1) | Third Molar (1) |
| Thixogel (1) | THP-1 (2) | Three component system (1) |
| thrombocytopenia (1) | Thrombolysed subjects (1) | Thrombolytic (1) |
| thrombolytic enzymes (1) | Thyme oleoresin (1) | Thyrotoxicosis. (1) |
| Tigecycline (1) | time dependent approach (1) | Time lag (1) |
| Timed release (1) | Tissue distribution (1) | TLC (1) |
| Tobacco (2) | Tobacco smoking (1) | tolbutamide (1) |
| Tolerance (1) | Tooth brush. (1) | Tooth Demineralization (1) |
| Toothpaste (1) | Toothpaste. (1) | Topical delivery. (1) |
| Topical. (1) | Total flavonoid (1) | Total flavonoid content (2) |
| Total phenolic (2) | Total phenolic content (1) | total polyphenolic content (1) |
| total quality management (1) | toxicity (5) | Toxicity. (2) |
| traditional medicine (2) | Training of Central sterile and supply department employees (1) | tramadol HCL (1) |
| Tramadol Hydrochloride (1) | Trans-cinnamic acid (1) | Trans-resveratrol (1) |
| Transcriptomics. (1) | transdermal (2) | transfer latency (1) |
| Transfersome (2) | Transfersomes. (1) | Translation (1) |
| Transmucosal (1) | Transmucosal patch (1) | Trauma induced external inflammatory root resorption (1) |
| Treatment (1) | Treatment adherence. (1) | Treatment outcomes (1) |
| Treatment success rate (1) | Triacylglycerol. (1) | Triamcinalone Acetonide (TRIA) (1) |
| Trichoderma reesei. (1) | Tricyclic antidepressants (TCA) (1) | Triglycerides (1) |
| Trigonella foenum graecum (1) | Trigonelline (1) | Trinidad & Tobago (1) |
| trinitrobenzene sulfonic acid (1) | Triphala (1) | triple distilled water (1) |
| Triterpenoid. (1) | Triterpenoids (1) | Triticum aestivum. (1) |
| Tropaeolum majus L (1) | tropicamide (1) | Troponin-I (1) |
| Trypsin (1) | TSLP (1) | Tuberculosis (5) |
| Tuberculosis/HIV (1) | Tumor response (1) | Turkey (1) |
| Turmeric (1) | Tween 80. (1) | Twisted (1) |
| Tylophora indica (1) | Tylophorinidine. (1) | type 2 diabetes (2) |
| Type 2 diabetes mellitus (1) | Type 2 diabetes mellitus. (1) | type 2 diabetes. (1) |
| UACR (1) | UCPMP Guidelines (1) | Ultra-Fast Liquid Chromatography (UFLCDAD) (1) |
| Ultrasonic assisted extraction (1) | ultrasonication-solvent evaporation technique (1) | Ultrasonography (1) |
| Unani (1) | Unani medicine (3) | Uncemented (1) |
| Underutilization of insulin. (1) | Unethical practices. (1) | Unique device identification (1) |
| Universities (1) | Unlicensed. (1) | Unnecessary use. (1) |
| Unused drugs (1) | Unused/Unwanted medicines (1) | UPLC/ESI-Q-TOF-MS/MS method Validation (1) |
| Urban area (1) | urea (2) | Uremic toxins (1) |
| Urinary Hydrogen Peroxide (1) | Urinary tract infection (UTI) (1) | Urine Albumin to Creatinine Ratio (1) |
| Urine volume (1) | urolithiasis (1) | Urtica dioica L (1) |
| Usefulness. (1) | Uterine fibroid (1) | Uterine fibroids (1) |
| Uterine Perforation. (1) | UV derivative spectrophotometry (1) | UV detection (2) |
| UV Spectrophotometric method (1) | UV spectrophotometry (2) | UV Spectroscopy (1) |
| UV-spectrophotometric method (1) | UV-spectrophotometry (2) | UV-Vis spectroscopy (1) |
| Vaccine (1) | Vaccine design (1) | vada (1) |
| vaginal gel (1) | Vaginitis. (1) | Vakrasana (1) |
| validation (20) | Validation. (1) | Valium (1) |
| Valproate (1) | valsartan (1) | Vanillin (1) |
| Vanillosmopsis arborea. (1) | vascular bundle (1) | vascular permeability (2) |
| vascular progenitors (1) | VED analysis (3) | VED analysis. (2) |
| VEGFR-2 (1) | Velpatasvir (1) | Venetoclax (1) |
| Venography and Hemangioma (1) | Venous malformations (VMs) (1) | verapamil (3) |
| Verapamil HCl (1) | Viability (1) | Vincristine. (1) |
| Vinegar (1) | VIPPS (Verified Internet Pharmacy Practice Sites) (1) | Virtual Screening (1) |
| Viscosity (1) | visible Spectrophotometry (1) | visible spectroscopy (1) |
| Visual analogue scale. (1) | Visual Analogues Score. (1) | Vitamin D (3) |
| Vitamin D deficiency (1) | Vitamin D. (1) | vitamin E (1) |
| vitamin E d-α-tocopheryl polyethylene glyco1000 succinate (1) | Vitamin. (1) | Vitex agnus Castus (1) |
| Vitex negundo (1) | Voltage–gated calcium channels (1) | Voriconazole (1) |
| warfarin (2) | Warning signs (1) | Water hyacinth (2) |
| web-based learning (1) | Weibull parameters (1) | West timor (1) |
| Western blot technique (1) | Wet gangrene (2) | wet granulation (2) |
| wetting time (1) | Wheat (1) | White/red patch (1) |
| WHO core indicators (1) | WHO prescribing indicator (1) | WHO-QOL BREF questionnaire (1) |
| WHO-UMC causality assessment system. (1) | Wilson disease (1) | Wistar rats. (1) |
| Withania somnifera. (1) | Withdrawal (1) | Women. (1) |
| Work protection (1) | Work Satisfaction (1) | World Anti-Doping Agency (1) |
| World Health Organization (1) | Wound Healing (1) | Wound tissue healing (1) |
| Wrightia tinctoria (1) | writhing (1) | X-ray diffraction (1) |
| X-ray imaging study. (1) | X-ray powder diffraction (1) | xanthan gum (1) |
| Xanthangum (1) | XDR-TB (1) | Xenografts (1) |
| Xenografts. (1) | XRD (1) | Xylitol (1) |
| Ylang-ylang (1) | Yoga (1) | Young (1) |
| Yucca gloriosa L. (1) | Zea m1 pollen allergen (1) | Zero order release (1) |
| zero order spectrophotometry (1) | zeta potential (1) | zidovudine (2) |
| Zika virus (1) | zinc (1) | Zinc ion (1) |
| Zingiber officinale (1) | Zingiberaceae (1) | zopiclone (1) |
| [BMIM]PF6 (1) | Þ rst-order derivative spectroscopy (1) | Α-amylase (3) |
| α-glucosidase (2) | α-mangostin (1) | β amyloid protein (1) |
| β Amyloid1-42 (1) | β-carboline (1) | β-carotene production (1) |
| β-cyclodextrin (3) | γ-oryzanol (1) | γ-retroviral vector (1) |
| ε-amino groups (1) | | |
